A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)

BACKGROUND: The recommendations outlined in the latest guidelines published by the Surgical Infection Society (SIS) and the Infectious Disease Society of America (IDSA) regarding the proper duration of antibiotic therapy in patients with intra-abdominal infections are limited and non-specific. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Coccolini, Federico, Catena, Fausto, Ansaloni, Luca, Ercolani, Giorgio, Di Saverio, Salomone, Gazzotti, Filippo, Lazzareschi, Daniel, Pinna, Antonio D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090366/
https://www.ncbi.nlm.nih.gov/pubmed/21501482
http://dx.doi.org/10.1186/1471-230X-11-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090366/
https://www.ncbi.nlm.nih.gov/pubmed/21501482
http://dx.doi.org/10.1186/1471-230X-11-42

Ejemplares similares